SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-16-000955
Filing Date
2016-05-23
Accepted
2016-05-23 16:17:31
Documents
35
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED MARCH 31, 2016 nnab-20160331_10q.htm 10-Q 211786
2 EXHIBIT 31.1 nnab-20160331_10qex31z1.htm EX-31.1 12111
3 EXHIBIT 32.1 nnab-20160331_10qex32z1.htm EX-32.1 5815
  Complete submission text file 0001520138-16-000955.txt   1082021

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nnab-20160331.xml EX-101.INS 135411
5 XBRL CALCULATION FILE nnab-20160331_cal.xml EX-101.CAL 16096
6 XBRL DEFINITION FILE nnab-20160331_def.xml EX-101.DEF 22021
7 XBRL LABEL FILE nnab-20160331_lab.xml EX-101.LAB 101360
8 XBRL PRESENTATION FILE nnab-20160331_pre.xml EX-101.PRE 76521
9 XBRL SCHEMA FILE nnab-20160331.xsd EX-101.SCH 13490
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 161669225
SIC: 2834 Pharmaceutical Preparations